A statistical study about knowledge pharmacy students with drugs indicated and contraindicated in pregnancy
Main Article Content
Keywords
medication treatment, pregnancy, acetaminophen, tetracycline, amoxicillin, health care.
Abstract
Background: Because of its specific physiological effects, medication treatment during pregnancy presents special safety issues. For the same reasons that a pregnant woman's own well-being and life are paramount, protecting the life of her unborn child is crucial.
Methods: Pharmacists are increasingly being asked by patients, families, and friends regarding drug use during pregnancy. Since this is not typically discussed in pharmacy school, some pharmacists may feel unprepared to confidently address these issues.
Results: (76.1%) of people filled out the survey. While just 22 percent of respondents believed that alprazolam was prescribed based on a risk-benefit analysis, 69.6 percent believed that the drug was unsafe. Additionally, 65.2% of CPs said amoxicillin is safe to take, whereas just 11.7% knew tetracycline should be used only if the benefits outweigh the risks. Most CPs (92.6%) knew that
acetaminophen is completely safe because it may be purchased without a prescription. When asked about the safety of vitamin A supplements, over half of all CPs (48.4%) gave a negative response. On the knowledge exam, CPs' performance varied significantly by age group (P = 0.001).
Conclusions: Even though community pharmacists are the most accessible health care professionals who can advise pregnant women on medication usage, there are still knowledge gaps in areas where training interventions are needed.
References
2. Zaganjor, A. Sekkarie, B. L. Tsang et al., “Describing the prevalence of neural tube defects worldwide: A systematic literature review,” PLoS ONE, vol. 11, no. 4, Article ID e0151586,2016.
3. S. Kacew, “Fetal consequences and risks attributed to the use of prescribed and over-thecounter (OTC) preparations during pregnancy,” International Journal of Clinical Pharmacology and Therapeutics, vol. 32, no. 7, pp. 335–343,1994.
4. W. S. Webster and J. A. Freeman, “Prescription drugs and pregnancy,” Expert Opinion on Pharmacotherapy, vol. 4, no. 6, pp. 949–961,
2005.
5. V. Erdelji´c, I. Franceti´c, K. Makar-Auˇsperger, R. Liki´c, and M. Radaˇci´c-Aumiler, “Clinical pharmacology consultation: a better answer to
safety issues of drug therapy during pregnancy?”
6. European Journal of Clinical Pharmacology, vol. 66, no. 10, pp. 1037–1046, 2010.
7. Fisher, N. C. Rose, and J. C. Carey, “Principles and practice of teratology for the obstetrician,” Clinical Obstetrics and Gynecology, vol. 51, no.1, pp. 106–118, 2008.
8. A. Nava-Ocampo and G. Koren, “Human teratogens and evidence-based teratogen risk counseling: the motherisk approach,” Clinical
Obstetrics and Gynecology, vol. 50, no. 1,pp.123–131, 2007.
9. M. Bullo, S. Tschumi, B. S. Bucher, M. G. Bianchetti, and G. D. Simonetti, “Pregnancy outcome following exposure to angiotensinconverting enzyme inhibitors or angiotensin receptor antagonists: a systematic review,”Hypertension, vol. 60, no. 2, pp. 444–450, 2012.
10. E. Kabuluzi, Assessment of risk of drug exposure in early pregnancy in women in a rural community in Malawi, [Doctoral dissertation], University ofManchester.
11. F. B´anhidy, R. Lowry, andA. E. Czeizel, “Risk andbenefitofdrug use during pregnancy,” International Journal ofMedical Sciences, vol. 2, no. 3, pp. 100–106, 2005.
12. de Tejada, “Antibiotic use and misuse during pregnancy and delivery: benefits and risks,” International Journal of Environmental Research and Public Health, vol. 11, no. 8, pp. 7993–8009,2014.
13. C. Vidal, S. K. Murphy, A. P. Murtha et al., “Associations between antibiotic exposure during pregnancy, birth weight and aberrantmethylation at imprinted genes among offspring,”International Journal of Obesity, vol. 37, no. 7, pp. 907–913, 2013.
14. K. B.Mensah, K. Opoku-Agyeman, and C. Ansah, “Antibiotic use during pregnancy: A retrospective study of prescription patterns and
birth outcomes at an antenatal clinic in rural Ghana,” Journal of Pharmaceutical Policy and Practice, vol. 10, no. 1, p. 24, 2017.
15. S. F.Widnes, “Drug information in pregnancy,” in Attitudes and Needs among Pregnant Women and Physicians, 2013.
16. Kamuhabwa and R. Jalal, “Drug use in pregnancy: Knowledge of drug dispensers and pregnant women in Dar es Salaam, Tanzania,”
Indian Journal of Pharmacology, vol. 43, no. 3, p. 345,2011.
17. S. Boonyaprapa, Self-care in pregnancy and breastfeeding: views of women and community pharmacists in Thailand, [Doctoral dissertation],University ofNottingham.
18. B. Farah, M. Mohamad, E. Ahmed M, and D. Souraya, Knowledge, Attitude And Practice of Community Pharmacists Towards Medications Use during Pregnancy, 2014.
19. Baldon, J.P., Correr, C.J., Melchiors, A.C., Rossignoli, P., Fernandez-Llimos, F., Pontarolo, R., 2006. Community pharmacists’ attitudes and knowledge on dispensing drugs to pregnant women. Pharm. Pract. 4 (1), 38–43.
20. Bercaw, J., Maheshwari, B., Sangi-Haghpeykar, H., 2010. The use during pregnancy of prescription, over-the-counter, and alternative
medications among Hispanic women. Birth 37,211–218.
21. Damase-Michel, C., Pichereau, J., Pathak, A., Lacroix, I., Montastruc, J.L., 2008. Perception of teratogenic and foetotoxic risk by health
professionals: a survey in Midi-Pyrenees area. Pharm. Pract. (Internet) 6, 15–19.
22. Garcia-Bournissen, F., Tsur, L., Goldstein, L.H., Staroselsky, A., Avner, M., Asrar, F., De Santis, M., 2008. Fetal exposure to isotretinoin – an international problem. Reprod. Toxicol. 25, 124–128.
23. George, J., 2011. Optimising medication use during pregnancy: the potential role of pharmacists. Int. J. Pharm. Pract. 19, 81–83.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.